Jarrah Mohamad I, Ababneh Muhannad J, Tawalbeh Loai Issa, Hammoudeh Ayman J, Barukba Hanan M, Othman Ahmad
Department of Internal Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Faculty of Nursing, Al al-Bayt University Al-Mafraq, P.O. Box: 130049, 25113, Jordan.
Ann Med Surg (Lond). 2020 Dec 29;61:148-154. doi: 10.1016/j.amsu.2020.12.036. eCollection 2021 Jan.
Statin eligibility based on the American College of Cardiology/American Heart Association cholesterol guidelines among patients with diabetes admitted with first time acute myocardial infarction has not been evaluated in the Middle East.
To assess statin eligibility for diabetic patients admitted with first time myocardial infarction in Jordan according to ACC/AHA guidelines.
Consecutive patients admitted with a first acute myocardial infarction who were not taking statins, and had their serum lipoproteins measured upon hospital admission were enrolled in the study. Statin eligibility among patients with diabetes admitted with first time myocardial infarction was determined based on the ACC/AHA guidelines.
Of 774 patients enrolled, 292 (37.30%) had diabetes. Compared with non-diabetic patients, those with diabetes were females, older, more hypertension, more hypercholesterolemia, more triglycerides, more diastolic blood pressure, less smokers and less low density lipoprotein. Among patients with diabetes, 242 diabetic patients (82.9%) were statin eligible, including 20 (6.90%) for having high serum levels of low density lipoprotein cholesterol (LDL-C) >190 mg/dL, and 222 (76%) for being aged 40-75 years with LDL-C 70-189 mg/dL. No patient had a calculated atherosclerotic cardiovascular risk score ≥7.5%. On the other hand, 393 non-diabetic patients (81.3%) were statin eligible, including 41 (8.50%) for having high serum levels of low density lipoprotein cholesterol (LDL-C) >190 mg/dL, and 351 (72.80%) for being aged 40-75 years with LDL-C 70-189 mg/dL.
Based on the ACC/AHA guidelines, the majority of patients with diabetes admitted with first acute myocardial infarction would have been eligible for statin treatment if they have LDL-c >190 mg/dl or aged 40-75 years old and they have their LDL 70-189 mg/gl. More efforts should be taken for patients who are female, older than 50 years, hypertensive, elevated diastolic blood pressure have hypercholesterolemia, and elevated triglycerides because of their significant association with diabetes.
中东地区尚未对首次因急性心肌梗死入院的糖尿病患者根据美国心脏病学会/美国心脏协会胆固醇指南使用他汀类药物的适宜性进行评估。
根据美国心脏病学会/美国心脏协会指南评估约旦首次因心肌梗死入院的糖尿病患者使用他汀类药物的适宜性。
连续纳入首次因急性心肌梗死入院且未服用他汀类药物、入院时检测了血清脂蛋白的患者。根据美国心脏病学会/美国心脏协会指南确定首次因心肌梗死入院的糖尿病患者使用他汀类药物的适宜性。
在纳入的774例患者中,292例(37.30%)患有糖尿病。与非糖尿病患者相比,糖尿病患者为女性、年龄更大、高血压更多、高胆固醇血症更多、甘油三酯更多、舒张压更高、吸烟者更少、低密度脂蛋白更低。在糖尿病患者中,242例(82.9%)符合使用他汀类药物的标准,其中20例(6.90%)血清低密度脂蛋白胆固醇(LDL-C)水平>190 mg/dL,222例(76%)年龄在40 - 75岁且LDL-C为70 - 189 mg/dL。没有患者的计算得出的动脉粥样硬化心血管风险评分≥7.5%。另一方面,393例非糖尿病患者(81.3%)符合使用他汀类药物的标准,其中41例(8.50%)血清低密度脂蛋白胆固醇(LDL-C)水平>190 mg/dL,351例(72.80%)年龄在40 - 75岁且LDL-C为70 - 189 mg/dL。
根据美国心脏病学会/美国心脏协会指南,如果首次因急性心肌梗死入院的糖尿病患者LDL-c>190 mg/dl或年龄在40 - 75岁且LDL为70 - 189 mg/gl,大多数患者符合他汀类药物治疗标准。对于女性、年龄超过50岁、高血压、舒张压升高、高胆固醇血症以及甘油三酯升高的患者,应做出更多努力,因为他们与糖尿病有显著关联。